Recent developments of protein kinase inhibitors as potential AD therapeutics

Present Alzheimer’s disease (AD) therapies suffer from inefficient effects on AD symptoms like memory or cognition, especially in later states of the disease. Used acteylcholine esterase inhibitors or the NMDA receptor antagonist memantine address one target structure which is involved in a complex,...

Descripción completa

Detalles Bibliográficos
Autores principales: Tell, Volkmar, Hilgeroth, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832900/
https://www.ncbi.nlm.nih.gov/pubmed/24312003
http://dx.doi.org/10.3389/fncel.2013.00189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832900/
https://www.ncbi.nlm.nih.gov/pubmed/24312003
http://dx.doi.org/10.3389/fncel.2013.00189

Ejemplares similares